Home » Topics » Regulatory

Regulatory
RSS

BMS and Sanofi-Synthelabo withdraw irbesartan sNDA

Feb. 8, 2002

Xopenex approved for pediatric use in bronchospasm

Feb. 7, 2002

Once-daily one-tablet formulation of Sustiva approved

Feb. 6, 2002

First approval obtained for antihypertensive combination developed in Spain

Feb. 5, 2002

Gleevec approved for gastrointestinal stromal tumors

Feb. 5, 2002

Zometa receives positive opinion for treatment of cancer-related bone metastases

Feb. 4, 2002

Amgen's Neulasta approved for febrile neutropenia

Feb. 4, 2002

Guilford seeks expansion of indications for Gliadel in Europe

Feb. 4, 2002

Approvable letter received for use of Altocor in hypercholesterolemia

Feb. 4, 2002

Alesse approved by Canadian authorities for treatment of acne

Feb. 1, 2002

Popular Stories

University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Beijing Innocare Pharma Tech discloses new GSPT1 degradation inducers
BioWorld Science
Beijing Innocare Pharma Tech Co. Ltd. has synthesized new antibody-drug conjugates comprising antibody or antigen-binding fragment covalently linked to eukaryotic...